Xtampza er and Fenofibrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xtampza er (oxycodone) and Fenofibrate (fenofibrate). Common drug interactions include chest pain among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Xtampza er and Fenofibrate. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Xtampza er?
Xtampza er has active ingredients of oxycodone. eHealthMe is studying from 1,502 Xtampza er users. Check the latest studies of Xtampza er.
What is Fenofibrate?
Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.
15 people who take Xtampza er and Fenofibrate together, and have interactions are studied.

What are the common drug interactions of Xtampza Er and Fenofibrate, by gender? *:
female:
- Chest pain
- Fall
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hypertension (high blood pressure)
- Insomnia (sleeplessness)
- Malaise (a feeling of general discomfort or uneasiness)
- May-thurner syndrome (a rarely diagnosed condition in which patients develop iliofemoral deep venous thrombosis (dvt) due to an anatomical variant)
- Pain
- Pneumonia
- Thrombosis (formation of a blood clot inside a blood vessel)
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Quality of life decreased
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
- Death
- Dyskinesia (abnormality or impairment of voluntary movement)
- Hypokinesia (decreased bodily movement)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
What are the common drug interactions of Xtampza Er and Fenofibrate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Back pain
- Chronic kidney disease
- Death
- Emotional distress
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Gait disturbance
- Hypoaesthesia (reduced sense of touch or sensation)
50-59:
- Chest pain
- Alopecia (absence of hair from areas of the body)
- Blood pressure diastolic increased
- Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
- Constipation
- Depression
- Diarrhoea
- Dysphagia (a condition in which swallowing is difficult or painful)
- Fatigue (feeling of tiredness)
- Glycosylated haemoglobin increased
60+:
- Pneumonia
What are the existing conditions these people have? *
- Renal Cell Carcinoma (a kidney cancer): 4 people, 26.67%
- Stress And Anxiety: 3 people, 20.00%
- Depression: 3 people, 20.00%
- High Blood Pressure: 3 people, 20.00%
- Pain: 2 people, 13.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
- Hiv Infection: 2 people, 13.33%
- Nausea (feeling of having an urge to vomit): 2 people, 13.33%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 13.33%
- Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 13.33%
* Approximation only. Some reports may have incomplete information.
Do you take Xtampza er and Fenofibrate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Xtampza er (1,502 reports)
- Fenofibrate (40,456 reports)
Browse all drug interactions of Xtampza er and Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xtampza er:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xtampza er and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fenofibrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on oxycodone and fenofibrate (the active ingredients of Xtampza er and Fenofibrate, respectively), and Xtampza er and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could St. John'S Wort cause Confusional State? - 12 seconds ago
- Drug interactions of Rizatriptan Benzoate and Prochlorperazine Maleate - 17 seconds ago
- Drug interactions of Alvesco and Tadalafil - 18 seconds ago
- Drug interactions of Aloxi and Calcium - 24 seconds ago
- Could Frova cause Suicidal Ideation? - 24 seconds ago
- Could Asmanex Hfa cause Stools - Watery? - 30 seconds ago
- Could Asmanex Hfa cause Diarrhea? - 31 seconds ago
- Drug interactions of Atazanavir and Zerit - 35 seconds ago
- Could Spironolactone cause Pulmonary Vascular Resistance Abnormality? - 36 seconds ago
- Could Loratadine cause Hypokalemia? - 40 seconds ago